Healthtech Startups

Human Life Code develops and commercializes novel therapeutics in specialty care areas such as cancer, autoimmune diseases, and retinal diseases. The company specializes in research, development, market launch, and lifecycle management of pharmaceutical products and regenerative medicine products.

1 investor

PharmaBio is Japan's first contract development and manufacturing organization (CDMO) for regenerative medicine and cell-based therapeutics. The company provides regulatory development support and manufacturing services for cell and tissue-derived pharmaceuticals.

1 investor

Physiologas develops technology to innovate healthcare and improve patient and family wellbeing. The company operates in the medical technology sector, based in Japan.

1 investor

Kamui Pharma develops therapeutic compounds derived from probiotics for treating inflammatory bowel disease and other diseases. The company conducts drug discovery research and clinical trials focused on novel bioactive molecules.

1 investor

PorMedTec develops transplantable organs and tissues using genetically modified pigs for manufacturing and commercializing as regenerative medicine products. The company targets patients and healthcare systems facing severe organ shortages by providing alternatives to dialysis and other symptom-based treatments.

1 investor

MiRNDa, Inc. is a Japanese biotech company developing in-vitro diagnostic (IVD) medical devices based on RNA modification technology to detect an early "stage 0" of cancer.

1 investor

Medeta develops AI and digital technology solutions to expand reproductive medicine techniques and services, making them reproducible and accessible to patients. The company applies artificial intelligence to fertility treatment workflows to enhance physician and embryologist expertise.

1 investor

Melody International develops mobile fetal and maternal monitoring medical devices, including the "iCTG" cardiotocograph and the "Central i" central monitoring system for perinatal care. The Japanese company provides remote maternal and fetal health monitoring for healthcare providers, with device registrations in Japan and international markets such as Thailand, Kenya, the Philippines, and Indonesia.

1 investor

Yakkle is an online medical service offering convenient digital healthcare for chronic disease management. The platform enables patients to consult with fixed physicians via LINE without appointments, receive medications at home, and conduct at-home blood tests for conditions like hypertension and diabetes.

1 investor

LEBER is a smartphone app offering a "doctor sharing platform" that lets users consult with physicians 24/7 and monitor their health. It is marketed to employers as a way to support employee health.

1 investor

A company developing radioactive pharmaceuticals for cancer treatment with enhanced visibility. The company focuses on accelerating the delivery of innovative diagnostic and therapeutic agents to patients and healthcare providers.

1 investor

Logic Inc. develops software solutions for the construction and healthcare sectors, including building design CAD tools, renovation simulation software, and home care management systems. The company also operates digital catalog platforms and has earned multiple patents in its core product areas.

1 investor

TaiMed Biologics is a Taiwan-based biopharmaceutical company that develops monoclonal antibody therapies for HIV, including the long-acting TMB-365/TMB-380 combination and the CD4-targeted ADC platform extending into autoimmune diseases. It also operates a cGMP protein manufacturing facility and provides CDMO services such as process development, analytical method development, formulation development, and commercial manufacturing for antibody products.

1 investor

Shanghai General Healthy Information & Technology develops intelligent medical logistics and automation equipment, including automated pharmacy dispensing systems marketed under the CONSIS and SANTO brands, for hospitals. Its products are used by over 1,000 large and medium-sized hospitals across more than 30 provinces in China.

1 investor

A research-driven specialty pharmaceutical company that develops and commercializes innovative medicines through the 505(b)(2) regulatory pathway, focusing on central nervous system disorders, metabolic diseases, and orphan indications. The company operates in New Jersey and Shanghai, leveraging established molecules with proven safety profiles.

1 investor

Pharmaron provides drug research and development services globally, supporting the discovery and development of pharmaceutical therapies through integrated capabilities across multiple geographic regions.

1 investor

Zylox-Tonbridge Medical is a Chinese medical device company developing clinical solutions and products, with a focus on neurovascular and peripheral vascular interventional treatments. It is publicly listed on the Hong Kong Stock Exchange (02190.HK).

1 investor

日本エマージェンシーアシスタンス (EAJ) is a Japan-based company providing medical assistance services internationally, including emergency medical support, travel assistance, and security assistance services for customers worldwide. The company also operates as a concierge service provider and offers crisis management services for international students.

1 investor

aceRNA Technologies develops therapies based on RNA technology, focusing on the discovery of new functions of miRNA to contribute to regenerative medicine and the creation of new drugs for diseases that currently lack treatments. The company operates in the biotech and drug discovery field.

1 investor

Amidex develops Amidex®, a digital index (template) system for composite resin dental treatment that lets dentists restore and reshape teeth with minimal cutting of healthy tooth structure. The company targets dental clinics, aiming to standardize low-invasive restorative dentistry across Japan.

1 investor

Arktus Therapeutics develops regenerative medicine treatments derived from iPS cells, initially focusing on knee joint diseases with plans to expand to additional organ systems. The company brings together clinical, research, and regulatory expertise to advance innovative cell-based therapeutic products.

1 investor

Ayumo develops a gait analysis device designed by orthopedic physicians to support people with walking difficulties in receiving early appropriate treatment and improving motor function.

1 investor

A medical technology platform that provides comprehensive solutions for healthcare facilities, including AI-powered appointment systems, electronic medical records, and online consultation services. The company targets medical institutions in Japan and focuses on operational optimization and patient engagement.

1 investor

eWeLL is a Japanese company that develops iBow, an IT platform for home-visit nursing operations. It provides electronic medical record and management software for home nursing care providers.

1 investor